Neonatology Research

Neonatal Research for Our Youngest Patients

Since offering our first pediatric cancer research study over two decades ago, we have grown to serve neonates, adolescents and young adults. Clinical needs, benefits and risks are carefully weighed when choosing research studies for all populations, including children. Mary Bridge researchers work together with the Research Institute to balance standard care treatments with research interventions.

Neonatal Investigators:

Neonatal Studies Accepting Patients



Study Number: MK-1654-002A Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1654 in Pre-Term and Full-Term Infants

Study Info

Principal Investigator(s): Timothy Murphy, MD

Study Coordinator: Karyna Boykin, [email protected], 253-403-9349

Respiratory Distress Syndrome

Chiesi RDS Neonates

Study Number: CCD-5633AA1-02—A multi-center, double-blind, randomized, single dose, active-controlled study to investigate the efficacy and safety of Synthetic Surfactant (CHF 5633) in comparison to Porcine Surfactant (Poractant Alfa, Curosurf®) in the treatment of preterm neonates with respiratory distress syndrome.

Study Info

Principal Investigator(s): Michael Kuluz, MD

Study CoordinatorJaney Barnhart, [email protected], 253-403-7258